Prostate News Archive
23-Jan-2011
Prostate-shrinking drug may help detect cancer
Study finds that men who used medication received more accurate readings on their prostate specific antigen tests. Uncovering The Genetics Of Prostate Cancer
prostate cancer is known to occur typically in older men. Yet some patients are younger than 50 years at the time of diagnosis. Scientists assume that these cases might be the key to understanding the biology of this disease. Early prostate cancer might be a subtype which is characterized by a relatively small number of genetic modifications. Cancer researchers believe it is likely that these ... Researchers believe driver mutations extremely promote development, growth of prostate cancer
Prostate cancer is known to occur typically in older men. Yet some patients are younger than 50 years at the time of diagnosis. Scientists assume that these cases might be the key to understanding the biology of this disease. Early prostate cancer might be a subtype which is characterized by a relatively small number of genetic modifications. MicroRNA suppresses prostate cancer stem cells and metastasis
A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells. miR-34a targets a surface protein common to cancer stem cells and associated with tumor development and metastasis. When the micro RNA stifles CD44, it inhibits formation of prostate stem cells. Researchers blocked tumor formation, shrunk tumors and inhibited ... Prostate cancer screening test under scrutiny
The PSA test is one of the most widely used screening tests in the United States for prostate cancer, which is the second leading cause of death among American men. Yet several randomized studies have reported little or no survival benefit for men who get the test.
Back to Prostate News Archive
